Arax Advisory Partners’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.34M | Buy |
111,938
+104,476
| +1,400% | +$4.84M | 0.04% | 466 |
|
|
2026
Q1 | $327K | Sell |
7,462
-1,118
| -13% | -$51K | 0.01% | 828 |
|
|
2025
Q4 | $380K | Sell |
8,580
-209,631
| -96% | -$9.03M | 0.01% | 723 |
|
|
2025
Q3 | $9.21M | Buy |
218,211
+216,084
| +10,159% | +$8.71M | 0.13% | 114 |
|
|
2025
Q2 | $78K | Buy |
2,127
+86
| +4% | +$3.19K | ﹤0.01% | 1046 |
|
|
2025
Q1 | $77.7K | Buy |
2,041
+342
| +20% | +$12.7K | 0.01% | 803 |
|
|
2024
Q4 | $64.3K | Buy |
1,699
+1,009
| +146% | +$40.3K | ﹤0.01% | 822 |
|
|
2024
Q3 | $28.1K | Buy |
690
+510
| +283% | +$19.3K | ﹤0.01% | 948 |
|
|
2024
Q2 | $6.17K | Buy |
+180
| New | +$5.67K | ﹤0.01% | 1499 |
|
|
2023
Q4 | – | Sell |
-31
| Closed | -$1.03K | – | 1394 |
|
|
2023
Q3 | $1.03K | Buy |
+31
| New | +$990 | ﹤0.01% | 1119 |
|
|
2023
Q2 | – | Sell |
-35
| Closed | -$954 | – | 1303 |
|
|
2023
Q1 | $954 | Buy |
35
+1
| +3% | +$28 | ﹤0.01% | 1111 |
|
|
2022
Q4 | $950 | Buy |
+34
| New | +$1.03K | ﹤0.01% | 1092 |
|
|
2022
Q2 | – | Sell |
-126
| Closed | -$4K | – | 1211 |
|
|
2022
Q1 | $4K | Buy |
126
+109
| +641% | +$3.21K | ﹤0.01% | 840 |
|
|
2021
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 1050 |
|
|
2021
Q3 | $1K | Buy |
+17
| New | +$585 | ﹤0.01% | 923 |
|
|
2020
Q2 | – | Sell |
-98
| Closed | -$3K | – | 700 |
|
|
2020
Q1 | $3K | Buy |
98
+2
| +2% | +$76 | ﹤0.01% | 609 |
|
|
2019
Q4 | $4K | Buy |
96
+1
| +1% | +$42 | ﹤0.01% | 527 |
|
|
2019
Q3 | $4K | Buy |
95
+2
| +2% | +$78 | ﹤0.01% | 529 |
|
|
2019
Q2 | $3K | Buy |
+93
| New | +$3.39K | ﹤0.01% | 540 |
|
|
2018
Q4 | $3K | Buy |
90
+2
| +2% | +$69 | ﹤0.01% | 515 |
|
|
2018
Q3 | $3K | Sell |
88
-155
| -64% | -$4.93K | ﹤0.01% | 553 |
|
|
2018
Q2 | $7K | Buy |
243
+2
| +0.8% | +$57 | ﹤0.01% | 367 |
|
|
2018
Q1 | $6K | Buy |
241
+159
| +194% | +$4.24K | ﹤0.01% | 365 |
|
|
2017
Q4 | $2K | Sell |
82
-773
| -90% | -$22.3K | ﹤0.01% | 422 |
|
|
2017
Q3 | $27K | Sell |
855
-591
| -41% | -$18.9K | 0.01% | 257 |
|
|
2017
Q2 | $48K | Buy |
1,446
+227
| +19% | +$7.51K | 0.02% | 229 |
|
|
2017
Q1 | $40K | Buy |
1,219
+747
| +158% | +$24K | 0.02% | 227 |
|
|
2016
Q4 | $15K | Buy |
+472
| New | +$14.6K | 0.01% | 288 |
|
Other funds holding OHI
Arax Advisory Partners's OHI Position: Q2 2026 in Review
Arax Advisory Partners increased its Omega Healthcare (OHI) stake by 1,400% in Q2 2026, buying an estimated $4.84M and bringing the position to 111,938 shares worth $5.34M. The position accounts for 0.04% of the portfolio, ranked #466.
Arax Advisory Partners first reported a position in OHI in Q4 2016 and has held it in 28 quarters since. The position peaked at $9.21M in Q3 2025. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- Arax Advisory Partners held 111,938 shares of Omega Healthcare worth $5.34M as of Q2 2026.
- Arax Advisory Partners bought 104,476 Omega Healthcare shares in Q2 2026, an estimated $4.84M.
- Omega Healthcare made up 0.04% of Arax Advisory Partners's portfolio in Q2 2026, its #466 holding.
- Arax Advisory Partners first reported a position in Omega Healthcare in Q4 2016 and has held it in 28 quarters since.
- Arax Advisory Partners's Omega Healthcare position peaked at $9.21M in Q3 2025.
- 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.